Novo Integrated Sciences, Inc. (NVOS)
NASDAQ: NVOS · IEX Real-Time Price · USD
0.451
-0.015 (-3.26%)
At close: Apr 19, 2024, 4:00 PM
0.460
+0.009 (1.95%)
After-hours: Apr 19, 2024, 5:34 PM EDT

Novo Integrated Sciences Cash Flow Statement

Millions USD. Fiscal year is Sep - Aug.
Year 20232022202120202019201820172016
Net Income
-13.21-32.85-4.46-4.92-0.39-2.11-0.74-0.34
Depreciation & Amortization
3.13.872.371.990.310.070.070.07
Share-Based Compensation
0.871.761.032.920.071.310.250
Other Operating Activities
7.0121.340.04-0.43-0.81-0.21-0.390.37
Operating Cash Flow
-2.24-5.88-1.02-0.44-0.82-0.93-0.810.1
Capital Expenditures
-0.05-0.19-0.26-0.01-0.11-0.18-0.04-0.05
Acquisitions
00.063.730-0.510-1.090
Change in Investments
00.3-0.470.67-0.23-0.040.38-0.41
Investing Cash Flow
-0.050.1630.66-0.84-0.22-0.75-0.46
Share Issuance / Repurchase
2.3307.340.113.250.023.390
Debt Issued / Paid
-1.57-0.44-3.02-0.39-0.18-0.03-0.13-0.06
Other Financing Activities
0.010.02-----0.150.47
Financing Cash Flow
0.76-0.434.32-0.273.07-0.013.110.4
Exchange Rate Effect
-0.230.03-0.070.04-0-0.060.240
Net Cash Flow
-1.76-6.116.23-0.021.41-1.221.790.04
Free Cash Flow
-2.29-6.07-1.28-0.45-0.93-1.11-0.850.05
Free Cash Flow Margin
-18.24%-51.75%-13.76%-5.77%-9.87%-12.51%-10.66%0.65%
Free Cash Flow Per Share
-0.23-2.08-0.52-0.20-0.43-0.54-0.480.03
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).